Loss of Alpha3(IV) collagen expression associated with corneal keratocyte activation

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 2, 2007, Pages 627-635

  Guerriero, Emily ^a   Chen, Jian ^a   Sado, Yoshikazu ^b   Mohan, Rajiv R ^c   Wilson, Steven E ^c   Funderburgh, James L ^a   SundarRaj, Nirmala ^a  

^a University of Pittsburgh School of Medicine   (United States)

^b Okayama   (Japan)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA1 CHAIN; COLLAGEN TYPE 4 ALPHA2 CHAIN; COLLAGEN TYPE 4 ALPHA3; COLLAGENASE; DYE; HEPARIN; INSULIN; KERATAN SULFATE; KERATOCAN; LUMICAN; MESSENGER RNA; PROTEOGLYCAN; REAGENT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; AUTOANTIGEN; EYE PROTEIN; ISOPROTEIN; PROTEOCHONDROITIN SULFATE; TYPE IV COLLAGEN ALPHA3 CHAIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL LEVEL; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORNEA CELL; CULTURE MEDIUM; DOWN REGULATION; ENZYMATIC DEGRADATION; FETAL CALF SERUM; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHOTOREFRACTIVE KERATECTOMY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STROMA CELL; SUPPLEMENTATION; WESTERN BLOTTING; ANIMAL; CORNEA STROMA; CYTOLOGY; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PHYSIOLOGY; TRANSACTIVATION;

ANIMALS; AUTOANTIGENS; BLOTTING, WESTERN; COLLAGEN TYPE IV; CORNEAL STROMA; EYE PROTEINS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; KERATAN SULFATE; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; PROTEIN ISOFORMS; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

EID: 33847761437     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0635     Document Type: Article

References (41)

1. Beales MP, Funderburgh JL, Jester JV, Hassell JR. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest Ophthalmol Vis Sci. 1999;40:1658-1663.
2. Jester JV, Barry-Lane PA, Cavanagh HD, Petroll WM. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996;15:505-516.
3. Funderburgh JL, Funderburgh ML, Mann MM, Corpuz L, Roth MR. Proteoglycan expression during transforming growth factor beta-induced keratocyte- myofibroblast transdifferentiation. J Biol Chem. 2001;276:44173-44178.
4. Long CJ, Roth MR, Tasheva ES, et al. Fibroblast growth factor-2 promotes keratan sulfate proteoglycan expression by keratocytes in vitro. J Biol Chem. 2000;275:13918-13923.
5. Jester JV, Budge A, Fisher S, Huang J. Corneal keratocytes: phenotypic and species differences in abundant protein expression and in vitro light-scattering. Invest Ophthalmol Vis Sci. 2005;46:2369-2378.
6. Jester JV, Ho-Chang J. Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res. 2003;77: 581-592.
7. Jester JV, Huang J, Barry-Lane PA, Kao WW, Petroll WM, Cavanagh HD. Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and nbronectin assembly. Invest Ophthalmol Vis Sci. 1999;40:1959-1967.
8. Jester JV, Barry PA, Lind GJ, Petroll WM, Garana R, Cavanagh HD. Corneal keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins. Invest Ophthalmol Vis Sci. 1994;35:730-743.
9. Kato T, Nakayasu K, Kanai A. Corneal wound healing: immunohistological features of extracellular matrix following penetrating keratoplasty in rabbits. Jpn J Ophthalmol. 2000;44:334-341.
10. Ljubimov AV, Alba SA, Burgeson RE, et al. Extracellular matrix changes in human corneas after radial keratotomy. Exp Eye Res. 1998;67:265-272.
11. Melles GRJ, SundarRaj N, Binder PS, et al. Immunohistochemical analysis of unsutured and sutured corneal wound-healing. Curr Eye Res. 1995;14:809-817.
12. SundarRaj N, Martin J, Hrinya N. Development and characterization of monoclonal antibodies to human type III procollagen. Biochem Biophys Res Commun. 1982;106:48-57.
13. Tuori A, Virtanen I, Aine E, Uusitalo H. The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. Graefes Arch Clin Exp Ophthalmol. 1997;235:222-229.
14. Maseruka H, Bonshek RE, Zardi L, Tullo AB, Ridgway AEA. Tenascin-C variants in wound healing of the human cornea. Vis Res. 1996;36(suppl):1326.
15. Vansetten GB, Koch JW, Tervo K, et al. Expression of tenascin and fibronectin in the rabbit cornea after excimer laser-surgery. Graefes Arch Clin Exp Ophthalmol. 1992;230:178-183.
16. Mulholland B, Tuft SJ, Khaw PT. Matrix metalloproteinase distribution during early corneal wound healing. Eye. 2005;19:584-588.
17. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retinal Eye Res. 2002;21:1-14.
18. Ye HQQ, Maeda M, Yu FSX, Azar DT. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest Ophthalmol Vis Sci. 2000;41: 2894-2899.
19. Azar DT, Hahn TW, Jain S, Yen YC, StetlerStevensen WG. Matrix metalloproteinases are expressed during wound healing after excimer laser keratectomy. Cornea. 1996;15:18-24.
20. Fini ME, Girard MT, Matsubara M, Bartlett JD. Unique regulation of the matrix metalloproteinase, gelatinase-B. Invest Ophthalmol Vis Sci. 1995;36:622-633.
21. Fini ME, Girard MT, Matsubara M. Collagenolytic gelatinolytic enzymes in corneal wound-healing. Acta Ophthalmol. 1992;70: 26-33.
22. Funderburgh JL, Mann MM, Funderburgh ML. Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. J Biol Chem. 2003;278:45629-45637.
23. Funderburgh JL, Chandler JW. Proteoglycans of rabbit corneas with nonperforating wounds. Invest Ophthalmol Vis Sci. 1989;30: 435-442.
24. Carlson EC, Wang IJ, Liu CY, Brannan P, Kao CWC, Kao WWY. Altered KSPG expression by keratocytes following corneal injury. Mol Vis. 2003;9:615-623.
25. SundarRaj N, Fite D, Belak R, et al. Proteoglycan distribution during healing of corneal stromal wounds in chick. Exp Eye Res. 1998;67:433-442.
26. Berryhill BL, Beales MP, Hassell JR. Production of prostaglandin D synthase as a keratan sulfate proteoglycan by cultured bovine keratocytes. Invest Ophthalmol Vis Sci. 2001;42:1201-1207.
27. Espana EM, Kawakita T, Liu CY, Tseng SC. CD34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-β1. Invest Ophthalmol Vis Sci. 2004;45:2985-2991.
28. Jester JV, Moller-Pedersen T, Huang J, et al. The cellular basis of corneal transparency: evidence for "corneal crystallins." J Cell Sci. 1999;112(pt 5):613-622.
29. Hassell JR, Schrecengost PK, Rada JA, SundarRaj N, Sossi G, Thoft RA. Biosynthesis of stromal matrix proteoglycans and basement membrane components by human corneal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:547-557.
30. Kalluri R. Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis. Cold Spring Harb Symp Quant Biol. 2002;67:255-266.
31. Hamano Y, Kalluri R. Tumstatin, the NC1 domain of alpha 3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochem Biophys Res Commun. 2005;333:292-298.
32. Ljubimov AV, Burgeson RE, Butkowski RJ, Michael AF, Sun TT, Kenney MC. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest. 1995;72:461-473.
33. Mohan RR, Hutcheon AE, Choi R, et al. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res. 2003;76:71-87.
34. Anderson SC, SundarRaj N. Regulation of a rho-associated kinase expression during the corneal epithelial cell cycle. Invest Ophthalmol Vis Sci. 2001;42:933-940.
35. Ninomiya Y, Kagawa M, Iyama K, et al. Differential expression of 2 basement-membrane collagen genes, Col4A6 and Col4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal-antibodies 1. J Cell Biol. 1995;130:1219-1229.
36. SundarRaj N, Willson J, Gregory JD, Damle SP. Monoclonal antibodies to proteokeratan sulfate of rabbit corneal stroma. Curr Eye Res. 1985;4:49-54.
37. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
38. Knudsen KA, Soler AP. Cadherin-mediated cell-cell interactions. Methods Mol Biol. 2000;137:409-440.
39. Musselmann K, Alexandrou B, Kane B, Hassell JR. Maintenance of the keratocyte phenotype during cell proliferation stimulated by insulin 1. J Biol Chem. 2005;280:32634-32639.
40. Maeshima Y, Colorado PC, Kalluri R. Two RGD-independent αvβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem. 2000;275:23745-23750.
41. Berryhill BL, Kader R, Kane B, Birk DE, Feng J, Hassell JR. Partial restoration of the keratocyte phenotype to bovine keratocytes made fibroblastic by serum. Invest Ophthalmol Vis Sci. 2002;43: 3416-3421.